TISSUE ROBERT S 4

What Happened
Robert S. Tissue, EVP of Financial Strategy at Burke & Herbert Financial Services Corp. (BHRB), was awarded 1,550 time-based restricted stock units (RSUs) on January 22, 2026. The Form 4 reports acquisition at $0.00 (code A — award/grant); each RSU will be settled in one share of common stock upon vesting. This is a compensation award, not an open‑market purchase or sale.

Key Details

• Transaction date: 2026-01-22; Form 4 filed 2026-02-19.
• Transaction type/code: Award (A); reported acquisition price $0.00.
• Grant size: 1,550 RSUs. Each RSU converts to one share when vested.
• Vesting: Three equal annual installments, subject to continued employment (footnote).
• Shares owned after transaction: Not specified in the provided filing.
• No 10b5-1 plan, tax-withholding details, or cashless sales noted in the filing.
• Filing timeliness: The Form 4 was filed 28 days after the grant date (Form 4s are normally due within two business days), so this appears to be a late filing.

Context
Time‑based RSUs are common executive compensation: they only become shares if/when they vest and typically carry forfeiture risk if the executive leaves before vesting. Awards are routine for retention and compensation and do not by themselves indicate buying or selling intent. Late reporting can draw regulatory scrutiny or corrective filings, but the award itself is a standard compensation action.